<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37178683</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1439-4286</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</Title><ISOAbbreviation>Horm Metab Res</ISOAbbreviation></Journal><ArticleTitle>Metabolomic Profile of Insulin Resistance Women with Systemic Lupus Erythematosus.</ArticleTitle><Pagination><StartPage>487</StartPage><EndPage>492</EndPage><MedlinePgn>487-492</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1055/a-2093-0260</ELocationID><Abstract><AbstractText>The aims of this study were in systemic lupus erythematosus (SLE) patients: 1) to compare the metabolomic profile of insulin resistance (IR) with controls and 2) to correlate the metabolomic profile with other IR surrogates and SLE disease variables and vitamin levels. In this cross-sectional study, serum samples were collected from women with SLE (n=64) and gender- and age-matched controls (n=71), which were not diabetic. Serum metabolomic profiling was performed using UPLC-MS-MS (Quantse score). HOMA and QUICKI were carried out. Serum 25(OH)D concentrations were measured by chemiluminescent immunoassay. In women with SLE, the metabolomic Quantose score significantly correlated with HOMA-IR, HOMA2-IR, and QUICKI. Although concentrations of IR metabolites were not different between SLE patients and controls, fasting plasma insulin levels were higher and insulin sensitivity lower in SLE women. Interestingly, the Quantose IR score was significantly correlated with complement C3 levels (r=0.7; p=0.001). 25 (OH)D did not correlate with any metabolite or the Quantose IR index. Quantose IR may be a useful tool for IR assessment. There was a possible correlation between the metabolomic profile and complement C3 levels. The implementation of this metabolic strategy may help develop biochemical insight into metabolic disorders in SLE.</AbstractText><CopyrightInformation>Thieme. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mungu&#xed;a-Realpozo</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Specialties Hospital UMAE, Instituto Mexicano del Seguro Social, Puebla, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendoza-Pinto</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5101-7705</Identifier><AffiliationInfo><Affiliation>Systemic Autoimmune Diseases Research Unit, Specialties Hospital UMAE, Instituto Mexicano del Seguro Social, Puebla, Mexico.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica de Oriente, Instituto Mexicano del Seguro Social, Ciudad de Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etchegaray-Morales</LastName><ForeName>Ivet</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osorio-Pe&#xf1;a</LastName><ForeName>Angel David</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe9;lez-Pelcastre</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Escamilla-M&#xe1;rquez</LastName><ForeName>Marco Antonio</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ay&#xf3;n-Aguilar</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Research in Health Coordination, Instituto Mexicano del Seguro Social, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xe9;ndez-Mart&#xed;nez</LastName><ForeName>Socorro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Research in Health Coordination, Instituto Mexicano del Seguro Social, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Carrasco</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Medicine School, Benemerita Universidad Autonoma de Puebla, Puebla, Mexico.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Horm Metab Res</MedlineTA><NlmUniqueID>0177722</NlmUniqueID><ISSNLinking>0018-5043</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003176">Complement C3</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007328">Insulin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="Y">Insulin Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003176" MajorTopicYN="N">Complement C3</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002853" MajorTopicYN="N">Chromatography, Liquid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007328" MajorTopicYN="N">Insulin</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>14</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>18</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37178683</ArticleId><ArticleId IdType="doi">10.1055/a-2093-0260</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>